 Irish Medical Times | Significant breakthrough for women with ER+HER2 Irish Medical Times However, advances in the field of oncology are providing new hope, and clinical trials on a new indication for the existing cancer drug Afinitor (everolimus, already widely indicated for advanced renal cell carcinoma, etc) in combination with a ... |
